ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.512,50
0,72%
S&P 500
5.224,16
0,03%
US Dollar vs BRL
5,1423
-0,08%
Bitcoin
62.781,45
2,16%
Brent Oil
83,165
0,95%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Idera Pharmaceuticals Inc (IDRA)

  7. Idera Pharmaceuticals Inc (IDRA) Notícias

IDRA

Idera Pharmaceuticals (IDRA)

Idera Pharmaceuticals Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:IDRA
DataHoraFonteTítuloCódigoCompanhia
29/06/202317:31Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:IDRAIdera Pharmaceuticals Inc
23/06/202320:20Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:IDRAIdera Pharmaceuticals Inc
17/05/202310:50Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:IDRAIdera Pharmaceuticals Inc
15/05/202318:08Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:IDRAIdera Pharmaceuticals Inc
13/04/202317:32Edgar (US Regulatory)Annual Report (10-k)NASDAQ:IDRAIdera Pharmaceuticals Inc
10/04/202317:41Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:IDRAIdera Pharmaceuticals Inc
03/04/202307:00Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NASDAQ:IDRAIdera Pharmaceuticals Inc
30/03/202317:52Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDRAIdera Pharmaceuticals Inc
28/03/202312:29Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:IDRAIdera Pharmaceuticals Inc
14/02/202319:00Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:IDRAIdera Pharmaceuticals Inc
01/02/202318:44Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:IDRAIdera Pharmaceuticals Inc
18/01/202318:46Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDRAIdera Pharmaceuticals Inc
17/01/202310:00GlobeNewswire Inc.Idera Pharmaceuticals Announces Name Change to Aceragen, Inc. and Provides Near-Term Strategic OutlookNASDAQ:IDRAIdera Pharmaceuticals Inc
09/12/202218:50Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:IDRAIdera Pharmaceuticals Inc
14/11/202218:05GlobeNewswire Inc.Idera Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate UpdateNASDAQ:IDRAIdera Pharmaceuticals Inc
28/09/202218:01Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:IDRAIdera Pharmaceuticals Inc
28/09/202217:09GlobeNewswire Inc.Idera Pharmaceuticals Acquires AceragenNASDAQ:IDRAIdera Pharmaceuticals Inc
09/08/202217:15GlobeNewswire Inc.Idera Pharmaceuticals Reports Second Quarter 2022 Financial ResultsNASDAQ:IDRAIdera Pharmaceuticals Inc
17/05/202209:04GlobeNewswire Inc.Idera Pharmaceuticals Shares Positive Results from Investigator-Sponsored Trial in Melanoma Patients at Amsterdam UMCNASDAQ:IDRAIdera Pharmaceuticals Inc
05/05/202217:15GlobeNewswire Inc.Idera Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate UpdateNASDAQ:IDRAIdera Pharmaceuticals Inc
31/03/202217:26Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:IDRAIdera Pharmaceuticals Inc
31/03/202217:15GlobeNewswire Inc.Idera Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate UpdateNASDAQ:IDRAIdera Pharmaceuticals Inc
14/12/202118:32GlobeNewswire Inc.Idera Pharmaceuticals Announces Tilsotolimod UpdatesNASDAQ:IDRAIdera Pharmaceuticals Inc
08/11/202118:14GlobeNewswire Inc.Idera Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate UpdateNASDAQ:IDRAIdera Pharmaceuticals Inc
09/08/202117:15GlobeNewswire Inc.Idera Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate UpdateNASDAQ:IDRAIdera Pharmaceuticals Inc
26/05/202107:05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:IDRAIdera Pharmaceuticals Inc
19/05/202107:02Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:IDRAIdera Pharmaceuticals Inc
18/05/202117:15GlobeNewswire Inc.Idera Pharmaceuticals Announces Corporate UpdatesNASDAQ:IDRAIdera Pharmaceuticals Inc
29/04/202117:10GlobeNewswire Inc.Idera Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate UpdateNASDAQ:IDRAIdera Pharmaceuticals Inc
28/04/202117:55Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:IDRAIdera Pharmaceuticals Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:IDRA

Seu Histórico Recente

NYSE
GMA
General Motors Pines
COIN
ELONONEUSD
ASTROELON
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados